Posts

Showing posts from July, 2019

Ginseng Compound K Esters for some Epilepsy, Autism and Cancers?

Image
Many natural products like Ginseng and Curcumin do have long known medicinal properties but suffer from extremely low bioavailability, which limits their benefit. Ginsenosides are compounds found in the Ginseng plant. They are metabolized by the gut flora into active compounds that include Compound K.   Compound K has been shown to have a variety of pharmacological actions such as anti-inflammatory, anti-oxidant, anti-cancer and vasorelaxation.   It also has interesting effects that relate to autism and other neurological disorders. Compound K (CK) has extremely low bioavailability (circa 5%) which limits it potential therapeutic benefit. There are expensive versions of ginseng that aim to maximize Compound K (CK) production in the gut, but they do nothing to improve how much gets from the gut into the bloodstream. It is possible to modify Compound K by making an ester. This ester has been shown to be highly bioavailable and that means the theoretic benefits, shown in test tub...

Azosemide in Autism – ça marche aussi / it works too

Image
Rathaus/City Hall in Hanover, Germany       Attribution:  Thomas Wolf,  www.foto-tw.de The short version of this post is that the old German diuretic Azosemide delivers the same autism benefit as the popular diuretic Bumetanide, but it has a different profile of diuresis.   Azosemide may indeed be more potent at blocking NKCC1 in the brain, but this needs to be investigated/confirmed.   For some people Azosemide will be a better choice than Bumetanide. The bulk of today’s post is really likely to be of interest only to bumetanide users and the French and German bumetanide researchers. I did suggest recently when I published version 5 of Monty’s PolyPill , that it is getting close to the final version.   Some of the potential remaining elements have already been written about in this blog, but I have not finished evaluating them.   Azosemide falls into this category. One theme within this blog has been to increase the “autism effect...

Home/Clinic based Photobiomodulation/Laser Therapy in Autism - acting on Light Sensitive Ion Channels, Mitochondria, Lymph Nodes and more

Image
Photobiomodulation underlying mechanisms at the cellular and molecular levels. Light at 600–850 nm is absorbed by the mitochondrial electron transfer chain and leads to upregulation of the neuronal respiratory capacity . The near-infrared light at range of 900– 1100 nm is absorbed by structured water clusters formed in or on a heat/light-gated ion channels . An increase in vibrational energy of water cluster leads to perturb the protein structure and opening the channel which ultimately allows modulation of intracellular Ca2+ levels. The absorption of green light by neuronal opsin photoreceptors (OPN2-5) activates transient receptor potential channels which causes nonselective permeabilization to Ca2+ , Na+ , and Mg2+ . The cryptochromes (a class of flavoprotein blue-light signaling receptors) absorb blue light and seems to activate the transducing cellular signals via part of the optic nerve to the suprachiasmatic nucleus in the brain, which is important in regulation of the circadian...